Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From www.prnewswire.com - June 19, 2012 1:43 PM
Neuralstem, Inc. announced that the first patient to receive stem cell transplantation in both regions of the spinal cord has been treated in the ongoing Phase I trial of its spinal cord neural stem cells in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). This is.........